Selection of the optimal long-acting injectable formulation of ivermectin for use in humans to target malaria vectors in Western Africa: evaluation of pharmacokinetics and mosquitocidal efficacy in cattle under laboratory conditions

Lamidi Zela, Sié Hermann Pooda, Angélique Porciani, Samuel Beneteau, André Barembaye Sagna, Sophie Le Lamer-Déchamps, Nicolas Moiroux, Cheick Oumar Wendpagnandé Ouédraogo, Anyirékun Fabrice Somé, Cédric Pennetier, Christophe Roberge, Adrien Marie Gaston Belem, Koumbobr Roch Dabiré, Guiguigbaza-Kossigan Dayo, Karine Mouline

Open source

DOI
10.1186/s13071-026-07263-x
Published
2026-05-06
Container
Parasites & Vectors
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13071-026-07263-x,
  title = {Selection of the optimal long-acting injectable formulation of ivermectin for use in humans to target malaria vectors in Western Africa: evaluation of pharmacokinetics and mosquitocidal efficacy in cattle under laboratory conditions},
  author = {Lamidi Zela and Sié Hermann Pooda and Angélique Porciani and Samuel Beneteau and André Barembaye Sagna and Sophie Le Lamer-Déchamps and Nicolas Moiroux and Cheick Oumar Wendpagnandé Ouédraogo and Anyirékun Fabrice Somé and Cédric Pennetier and Christophe Roberge and Adrien Marie Gaston Belem and Koumbobr Roch Dabiré and Guiguigbaza-Kossigan Dayo and Karine Mouline},
  year = {2026},
  journal = {Parasites \& Vectors},
  doi = {10.1186/s13071-026-07263-x},
  url = {https://doi.org/10.1186/s13071-026-07263-x}
}

RIS

TY  - JOUR
TI  - Selection of the optimal long-acting injectable formulation of ivermectin for use in humans to target malaria vectors in Western Africa: evaluation of pharmacokinetics and mosquitocidal efficacy in cattle under laboratory conditions
AU  - Lamidi Zela
AU  - Sié Hermann Pooda
AU  - Angélique Porciani
AU  - Samuel Beneteau
AU  - André Barembaye Sagna
AU  - Sophie Le Lamer-Déchamps
AU  - Nicolas Moiroux
AU  - Cheick Oumar Wendpagnandé Ouédraogo
AU  - Anyirékun Fabrice Somé
AU  - Cédric Pennetier
AU  - Christophe Roberge
AU  - Adrien Marie Gaston Belem
AU  - Koumbobr Roch Dabiré
AU  - Guiguigbaza-Kossigan Dayo
AU  - Karine Mouline
PY  - 2026
JO  - Parasites & Vectors
DO  - 10.1186/s13071-026-07263-x
UR  - https://doi.org/10.1186/s13071-026-07263-x
ER  - 

APA

Zela, L., Pooda, S. H., Porciani, A., Beneteau, S., Sagna, A. B., Lamer-Déchamps, S. L., Moiroux, N., Ouédraogo, C. O. W., Somé, A. F., Pennetier, C., Roberge, C., Belem, A. M. G., Dabiré, K. R., Dayo, G., & Mouline, K. (2026). Selection of the optimal long-acting injectable formulation of ivermectin for use in humans to target malaria vectors in Western Africa: evaluation of pharmacokinetics and mosquitocidal efficacy in cattle under laboratory conditions. Parasites & Vectors. https://doi.org/10.1186/s13071-026-07263-x

Source records